Patents by Inventor Antti Pohjakallio

Antti Pohjakallio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-(1-heteroarylpiperazin-4-yl)methyl-1,4-benzodioxane derivatives as alpha2C antagonists
    Patent number: 10774074
    Abstract: Compounds of formula I, wherein A is an optionally substituted five-membered unsaturated heterocyclic ring containing 1, 2, or 3 N, O, or S ring heteroatom(s) exhibit alpha2C antagonistic activity and are thus useful for the treatment of diseases or conditions of the peripheric or central nervous system.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: September 15, 2020
    Assignee: ORION CORPORATION
    Inventors: Shouming Wang, Esa Kumpulainen, Jarmo Pystynen, Antti Pohjakallio, Anssi Haikarainen
  • 2-(1-HETEROARYLPIPERAZIN-4-YL)METHYL-1,4-BENZODIOXANE DERIVATIVES AS ALPHA2C ANTAGONISTS
    Publication number: 20190292170
    Abstract: Compounds of formula I, wherein A is an optionally substituted five-membered unsaturated heterocyclic ring containing 1, 2, or 3 N, O, or S ring heteroatom(s) exhibit alpha2C antagonistic activity and are thus useful for the treatment of diseases or conditions of the peripheric or central nervous system.
    Type: Application
    Filed: June 3, 2016
    Publication date: September 26, 2019
    Applicant: ORION CORPORATION
    Inventors: Shouming WANG, Esa KUMPULAINEN, Jarmo PYSTYNEN, Antti POHJAKALLIO, Anssi HAIKARAINEN
  • BENZODIOXANE DERIVATIVES AND THEIR PHARMACEUTICAL USE
    Publication number: 20190152992
    Abstract: Compounds of formula I, wherein Ra and Rb are as defined in the claims, exhibit alpha2C antagonistic activity and are thus useful as alpha2C antagonists.
    Type: Application
    Filed: June 28, 2017
    Publication date: May 23, 2019
    Inventors: Anssi HAIKARAINEN, Esa KUMPULAINEN, Antti POHJAKALLIO, Jarmo PYSTYNEN, Shouming WANG
  • 2-(1-HETEROARYLPIPERAZIN-4-YL)METHYL-1,4-BENZODIOXANE DERIVATIVES AS ALPHA2C ANTAGONISTS
    Publication number: 20180215739
    Abstract: Compounds of formula I, wherein A is an optionally substituted five-membered unsaturated heterocyclic ring containing 1, 2, or 3 N, O, or S ring heteroatom(s) exhibit alpha2C antagonistic activity and are thus useful for the treatment of diseases or conditions of the peripheric or central nervous system.
    Type: Application
    Filed: June 3, 2016
    Publication date: August 2, 2018
    Applicant: ORION CORPORATION
    Inventors: Shouming WANG, Esa KUMPULAINEN, Jarmo PYSTYNEN, Antti POHJAKALLIO, Anssi HAIKARAINEN
  • Alpha2 adrenoceptor agonists
    Patent number: 9249127
    Abstract: Compounds of formula (I), wherein X and R1-R6, are as defined in the claims, exhibit alpha2 agonistic activity and thus are useful as alpha2 agonists, especially as alpha2A agonists. Methods of use of said compounds are also provided.
    Type: Grant
    Filed: March 28, 2013
    Date of Patent: February 2, 2016
    Assignee: ORION CORPORATION
    Inventors: Tuula Koskelainen, Tero Linnanen, Anna Minkkilä, Mikko Mäkelä, Antti Pohjakallio
  • NEW ALPHA2 ADRENOCEPTOR AGONISTS
    Publication number: 20150065550
    Abstract: Compounds of formula (I), wherein X and R1-R6, are as defined in the claims, exhibit alpha2 agonistic activity and thus are useful as alpha2 agonists, especially as alpha2A agonists. Methods of use of said compounds are also provided.
    Type: Application
    Filed: March 28, 2013
    Publication date: March 5, 2015
    Inventors: Tuula Koskelainen, Tero Linnanen, Anna Minkkilä, Mikko Mäkelä, Antti Pohjakallio